Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

NCT05768880 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Intrinsic Pontine Glioma
Diffuse Midline Glioma
Recurrent CNS Tumor, Adult
Recurrent, CNS Tumor, Childhood
Refractory Primary Malignant Central Nervous System Neoplasm

Interventions

BIOLOGICAL: SC-CAR4BRAIN

Sponsor

Seattle Children's Hospital